These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31915129)

  • 1. Computational Staining of Pathology Images to Study the Tumor Microenvironment in Lung Cancer.
    Wang S; Rong R; Yang DM; Fujimoto J; Yan S; Cai L; Yang L; Luo D; Behrens C; Parra ER; Yao B; Xu L; Wang T; Zhan X; Wistuba II; Minna J; Xie Y; Xiao G
    Cancer Res; 2020 May; 80(10):2056-2066. PubMed ID: 31915129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer.
    Rączkowska A; Paśnik I; Kukiełka M; Nicoś M; Budzinska MA; Kucharczyk T; Szumiło J; Krawczyk P; Crosetto N; Szczurek E
    BMC Cancer; 2022 Sep; 22(1):1001. PubMed ID: 36131239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ConvPath: A software tool for lung adenocarcinoma digital pathological image analysis aided by a convolutional neural network.
    Wang S; Wang T; Yang L; Yang DM; Fujimoto J; Yi F; Luo X; Yang Y; Yao B; Lin S; Moran C; Kalhor N; Weissferdt A; Minna J; Xie Y; Wistuba II; Mao Y; Xiao G
    EBioMedicine; 2019 Dec; 50():103-110. PubMed ID: 31767541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence Will Not Replace Health Professionals, but the Proper Use of Artificial Intelligence Will Make Health Professionals Better.
    Rodriguez-Antolin C
    Cancer Res; 2020 May; 80(10):1912-1913. PubMed ID: 32414836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined expert-in-the-loop-random forest multiclass segmentation U-net based artificial intelligence model: evaluation of non-small cell lung cancer in fibrotic and non-fibrotic microenvironments.
    Saqi A; Liu Y; Politis MG; Salvatore M; Jambawalikar S
    J Transl Med; 2024 Jul; 22(1):640. PubMed ID: 38978066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors.
    Park C; Jeong DY; Choi Y; Oh YJ; Kim J; Ryu J; Paeng K; Lee SH; Ock CY; Lee HY
    Front Immunol; 2022; 13():1038089. PubMed ID: 36660547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence-quantified tumour-lymphocyte spatial interaction predicts disease-free survival in resected lung adenocarcinoma: A graph-based, multicentre study.
    Feng Z; Lin H; Liu Z; Yan L; Wang Y; Li B; Liu E; Han C; Shi Z; Lu C; Liu Z; Pang C; Li Z; Cui Y; Pan X; Chen X
    Comput Methods Programs Biomed; 2023 Aug; 238():107617. PubMed ID: 37235970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence.
    Enfield KSS; Martin SD; Marshall EA; Kung SHY; Gallagher P; Milne K; Chen Z; Nelson BH; Lam S; English JC; MacAulay CE; Lam WL; Guillaud M
    J Immunother Cancer; 2019 Jan; 7(1):13. PubMed ID: 30651131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An artificial intelligence-based ecological index for prognostic evaluation of colorectal cancer.
    Chen Q; Cai M; Fan X; Liu W; Fang G; Yao S; Xu Y; Li Q; Zhao Y; Zhao K; Liu Z; Chen Z
    BMC Cancer; 2023 Aug; 23(1):763. PubMed ID: 37592224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology.
    Failmezger H; Muralidhar S; Rullan A; de Andrea CE; Sahai E; Yuan Y
    Cancer Res; 2020 Mar; 80(5):1199-1209. PubMed ID: 31874858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
    Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of imaging and transcriptomic data of the immune landscape associated with tumor metabolism in lung adenocarcinoma: Clinical and prognostic implications.
    Choi H; Na KJ
    Theranostics; 2018; 8(7):1956-1965. PubMed ID: 29556367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
    He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
    J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma.
    Kim A; Lee SJ; Ahn J; Park WY; Shin DH; Lee CH; Kwon H; Jeong YJ; Ahn HY; I H; Kim YD; Cho JS
    PLoS One; 2019; 14(11):e0224430. PubMed ID: 31743333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.
    Jiang M; Wu C; Zhang L; Sun C; Wang H; Xu Y; Sun H; Zhu J; Zhao W; Fang Q; Yu J; Chen P; Wu S; Zheng Z; He Y; Zhou C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Cell-Specific Major Histocompatibility Complex II Expression as a Determinant of the Immune Infiltrate Organization and Function in the NSCLC Tumor Microenvironment.
    Johnson AM; Boland JM; Wrobel J; Klezcko EK; Weiser-Evans M; Hopp K; Heasley L; Clambey ET; Jordan K; Nemenoff RA; Schenk EL
    J Thorac Oncol; 2021 Oct; 16(10):1694-1704. PubMed ID: 34048945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.